Status:
UNKNOWN
Sepsis Prediction by Monocyte Distribution Width and Procalcitonin
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Sepsis
Diagnoses Disease
Eligibility:
All Genders
18+ years
Brief Summary
The mortality rate of sepsis remains as high as 30 to 40%. Early diagnosis and treatment of patients with sepsis reduce mortality significantly. The most commonly used biomarkers in clinical practice ...
Eligibility Criteria
Inclusion
- Subject Inclusion Criteria
- Adult ≥20 years) subjects presenting to the ED with the chief complaints of fever, altered consciousness, hypotension, and dyspnea. CBC with differential testing performed, at presentation as part of their standard medical care.
- Subjects who have signed Informed Consent.
- Subject Exclusion Criteria
- Previously enrolled in this study (i.e. subjects may not be enrolled more than once in this study)
- Subjects discharged from the ED \<72 hours
- Pregnant women
- Subjects not able to understand or sign Informed Consent
Exclusion
Key Trial Info
Start Date :
April 16 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2020
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04322942
Start Date
April 16 2019
End Date
September 30 2020
Last Update
March 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital, Linkou Medical Center
Taoyuan District, 新北市, Taiwan, 333